Philips reinforces commitment to connected solutions across the health continuum at SLEEP 2015

June 8, 2015

Seattle, Washington – Philips Respironics, a business of Royal Philips (NYSE: PHG, AEX: PHIA), will showcase its latest portfolio of sleep-disordered breathing solutions June 8-10 at SLEEP 2015, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. Philips is building the next generation of sleep products and services that span the care continuum, enabling healthcare professionals to make better use of information, and enhancing compliance to therapy through patient engagement.


“Our solutions bring together the right clinical therapies, sleep masks and data analytics in order to create a more comfortable and engaging patient experience and to achieve enhanced clinical efficiency,” said Teofilo Lee-Chiong, M.D., Chief Medical Liaison, Philips. “This year’s SLEEP conference will showcase the next evolution of Philips’ sleep solutions. We will share our successes in helping health professionals and providers streamline high-touch models of medical care to maximize the benefits that patients receive from using our technology.”


Leveraging the power of the HealthSuite Digital Platform (HSDP), an open and interoperable cloud-based IT structure to support the secure collection, analysis and sharing of health related data, Philips is ushering its customers into a new era in collaborative, connected care while empowering patients to take a more active role in their personal health.


Philips sleep-disordered breathing portfolio connects the provider and the patient at every point along the care journey, from diagnosis, through therapy compliance and ongoing use. It is designed to meet today’s industry challenges by:

·         Driving increased patient adherence

·         Increasing operational and staff efficiencies

·         Increasing revenues through optimum patient care


At SLEEP 2015, Philips will display its new solutions in home sleep testing, PAP therapy, masks, and programs that enhance patient engagement, boost compliance rates and improve long-term care. These solutions, part of Philips’ The ANSWER three-phase approach to sleep therapy, work together as a seamless, connected system to address the key aspects in the sleep patient’s journey from set-up, to compliance, through ongoing patient management. Recent additions to Philips’ sleep portfolio include:


·         Alice NightOne – A home sleep disorder diagnostic system, Alice NightOne offers lab- quality test results from the patient’s home. Fully compatible with the Philips Somnolyzer scoring solution, sleep technicians can read the results from the Alice NightOne and determine a score in 50-85 percent less time and with great accuracy[1], speeding time to diagnosis and treatment.

·         Amara View full-face mask – A minimal contact, full face mask, Amara View’s under-the-nose design prevents red marks, discomfort and irritation on the nose. It also offers the widest field of vision of leading full face masks and allows patients to wear their glasses, read and watch TV while wearing their mask[2].

·         Pico nasal mask - Designed to maximize comfort and effectiveness, Pico is the smallest and lightest traditional[3] mask available on the market to treat OSA, making minimal contact with the face, while still providing a tight seal.


To see the entire portfolio of sleep-disordered breathing products, visit the Philips Respironics booth (#601) at Sleep 2015. For more information on Philips’ advanced solutions for sleep and respiratory care and for updates from the show, follow @PhilipsResp and the Philips Respironics Facebook page.


[1] Data on file, Philips internal study

[2] Data from external and internal testing on file with Philips Respironics

[3] Data from external and internal testing on file with Philips Respironics

For further information, please contact:

Alicia Cafardi





About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 105,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at


You are about to visit a Philips global content page

You are about to visit the Philips USA website.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.